{"organizations": [], "uuid": "ad977f89aaf8de973f754254f612bcdba4fdfbde", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-evofem-biosciences-receives-fast-t/brief-evofem-biosciences-receives-fast-track-designation-for-amphora-for-prevention-of-chlamydia-idUSFWN1QB0HH", "country": "US", "domain_rank": 408, "title": "BRIEF-Evofem Biosciences Receives Fast Track Designation For Amphora For Prevention Of Chlamydia", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-21T14:02:00.000+02:00", "replies_count": 0, "uuid": "ad977f89aaf8de973f754254f612bcdba4fdfbde"}, "author": "", "url": "https://www.reuters.com/article/brief-evofem-biosciences-receives-fast-t/brief-evofem-biosciences-receives-fast-track-designation-for-amphora-for-prevention-of-chlamydia-idUSFWN1QB0HH", "ord_in_thread": 0, "title": "BRIEF-Evofem Biosciences Receives Fast Track Designation For Amphora For Prevention Of Chlamydia", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "amphora for prevention of chlamydia february", "sentiment": "negative"}, {"name": "reuters) - evofem biosciences inc", "sentiment": "none"}, {"name": "amphora for prevention of chlamydia reuters staff", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "February 21, 2018 / 12:05 PM / in 12 minutes BRIEF-Evofem Biosciences Receives Fast Track Designation For Amphora For Prevention Of Chlamydia Reuters Staff Feb 21 (Reuters) - Evofem Biosciences Inc: * EVOFEM BIOSCIENCES RECEIVES FAST TRACK DESIGNATION FOR AMPHORA FOR PREVENTION OF CHLAMYDIA * EVOFEM BIOSCIENCES INC - DATA FROM AMPHORA PHASE 3 TRIAL IS EXPECTED IN Q1 OF 2019 Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-02-21T14:02:00.000+02:00", "crawled": "2018-02-21T14:21:40.015+02:00", "highlightTitle": ""}